AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17047644 — intervention group
Group type: EXPERIMENTAL
Intervention: Six courses of carboplatin (AUC 4) and vinorelbine (25 mg/m²)
Number of subjects: 297
Study 17047644 — intervention group
Group type: COMPARATOR
Intervention: Three courses of carboplatin and vinorelbine
Number of subjects: 297
Study 17047644 — intervention group
Group type: EXPERIMENTAL
Intervention: Six courses of carboplatin and vinorelbine
Number of subjects: 297
Study 15130190 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontingent success
Number of subjects: 72
Study 15130190 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent failure
Number of subjects: 72
Study 10938488 — intervention group
Group type: EXPERIMENTAL
Intervention: NYHA classification
Number of subjects: 143
Study 10938488 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldman Activity Scale Classification (GASC)
Number of subjects: 143
Study 10938488 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak O(2) consumption (pVO(2))
Number of subjects: 143
Study 10938488 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic threshold (AT)
Number of subjects: 143
Study 10938488 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐min walk test (6‐MWT)
Number of subjects: 143
Study 9493672 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NPPV) with BiPAP 1.2/0.5 kPa
Number of subjects: 18
Study 9493672 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NPPV) with BiPAP 1.6/0.5 kPa
Number of subjects: 18
Study 8335701 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0
Study 8335701 — intervention group
Group type: COMPARATOR
Intervention: Maprotiline
Number of subjects: 0
Study 8335701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3772801 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (C)
Number of subjects: 9
Study 3772801 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee (D)
Number of subjects: 9
Study 29170486 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-particle size emulsion (LPE) - diameter 0.759 μm, 10 g lipid emulsion, 190 g yoghurt
Number of subjects: 20
Study 29170486 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-particle size emulsion (SPE) - diameter 0.290 μm, 10 g lipid emulsion, 190 g yoghurt
Number of subjects: 20
Study 29170486 — intervention group
Group type: COMPARATOR
Intervention: Control non-emulsion (NE) - 10 g non-emulsion lipid, 190 g yoghurt
Number of subjects: 20
Study 26267219 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine (1 mg/ml)
Number of subjects: 0
Study 26267219 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine (0.5 mg/ml)
Number of subjects: 0
Study 26267219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26267219 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine
Number of subjects: 0
Study 26267219 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatments (Rupatadine and Desloratadine)
Number of subjects: 0
Study 25302460 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using a GaAlAs laser (830 nm, 100 mW, illuminated area 0.028 cm2, 3.57 W/cm2, 20 sec, 2.0 J, 71 J/cm2), applied punctually in the major salivary glands, twice a week for 6 weeks (total of 12 sessions)
Number of subjects: 23
Study 25302460 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 23
Study 22130398 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-sided games (SSGs)
Number of subjects: 22
Study 22130398 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intermittent training (HIT)
Number of subjects: 22
Study 22130398 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 22
Study 20216293 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispot 532-nm pattern scan laser (PASCAL)
Number of subjects: 60
Study 20216293 — intervention group
Group type: COMPARATOR
Intervention: 532-nm solid-state green laser (GLX)
Number of subjects: 60
Study 18166407 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide/timolol fixed combination (DTFC) twice daily for 6 months
Number of subjects: 53
Study 18166407 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost every evening for 6 months
Number of subjects: 53
Study 18166407 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 53
Study 18166407 — intervention group
Group type: COMPARATOR
Intervention: Dorzolamide/timolol fixed combination (DTFC)
Number of subjects: 53
Study 16202351 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction and fixation
Number of subjects: 298
Study 16202351 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar hemiarthroplasty
Number of subjects: 298
Study 16202351 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty
Number of subjects: 298
Study 16202351 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 298
Study 12822347 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation with Kirschner wire for radius-humeral joint (without ulna fixation)
Number of subjects: 78
Study 12822347 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation with Kirschner wire for both radius-humeral joint and ulna fracture
Number of subjects: 78
Study 11167307 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral creatine supplementation (20 g d(‐1) for 7 days)
Number of subjects: 20
Study 11167307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8872689 — intervention group
Group type: COMPARATOR
Intervention: succinylcholine 1.0 mg/kg
Number of subjects: 70
Study 8872689 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rocuronium 0.6 mg/kg and mivacurium 0.15 mg/kg
Number of subjects: 70
Study 8872689 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg/kg
Number of subjects: 70
Study 1642441 — intervention group
Group type: EXPERIMENTAL
Intervention: Cibenzoline (390 mg/day in 3 divided doses)
Number of subjects: 18
Study 1642441 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone (900 mg/day in 3 divided doses)
Number of subjects: 18
Study 1642441 — intervention group
Group type: EXPERIMENTAL
Intervention: Cibenzoline
Number of subjects: 18
Study 1642441 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 18
Study 6472796 — intervention group
Group type: EXPERIMENTAL
Intervention: Solcoseryl Eye-Gel
Number of subjects: 99
Study 6472796 — intervention group
Group type: COMPARATOR
Intervention: Cysteine Eye-Gel
Number of subjects: 99
Study 30585373 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan loading (increased brain serotonin synthesis)
Number of subjects: 85
Study 30585373 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (decreased brain serotonin synthesis)
Number of subjects: 85
Study 30585373 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no specific intervention mentioned)
Number of subjects: 85
Study 29986174 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicated patients with MDD
Number of subjects: 121
Study 29986174 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 121
Study 27383495 — intervention group
Group type: EXPERIMENTAL
Intervention: Linkus syrup
Number of subjects: 360
Study 27383495 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline with Diphenhydramine
Number of subjects: 360
Study 27383495 — intervention group
Group type: COMPARATOR
Intervention: Acefyllin Piperazine with Diphenhydramine
Number of subjects: 360
Study 24660156 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 15 mg/kg
Number of subjects: 60
Study 24660156 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 10 mg/kg
Number of subjects: 60
Study 24660156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22572984 — intervention group
Group type: EXPERIMENTAL
Intervention: Preseasonal immunotherapy with olive pollen allergoid
Number of subjects: 437
Study 20818886 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofiltered C1 inhibitor concentrate (1000 units)
Number of subjects: 90
Study 20818886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 18631168 — intervention group
Group type: EXPERIMENTAL
Intervention: CREG-matched PLT transfusions
Number of subjects: 73
Study 18631168 — intervention group
Group type: COMPARATOR
Intervention: Crossmatch-selected PLT transfusions
Number of subjects: 73
Study 18631168 — intervention group
Group type: EXPERIMENTAL
Intervention: TMM
Number of subjects: 73
Study 18631168 — intervention group
Group type: EXPERIMENTAL
Intervention: EMM
Number of subjects: 73
Study 18631168 — intervention group
Group type: EXPERIMENTAL
Intervention: CREG
Number of subjects: 73
Study 18631168 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossmatching
Number of subjects: 73
Study 15891330 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous translaryngeal tracheostomy (TLT)
Number of subjects: 139
Study 15891330 — intervention group
Group type: COMPARATOR
Intervention: Surgical tracheostomy (ST)
Number of subjects: 139
Study 15891330 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 139
Study 12760854 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 4047
Study 12760854 — intervention group
Group type: COMPARATOR
Intervention: Comparator drugs
Number of subjects: 4047
Study 10594475 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (10 mg three times daily for 4 consecutive days)
Number of subjects: 10
Study 10594475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol ingestion on an empty stomach
Number of subjects: 10
Study 10594475 — intervention group
Group type: COMPARATOR
Intervention: No drug treatment (control)
Number of subjects: 10
Study 7795940 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical practice (one session)
Number of subjects: 60
Study 7795940 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical practice (two sessions)
Number of subjects: 60
Study 7795940 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginary practice (one session)
Number of subjects: 60
Study 7795940 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginary practice (two sessions)
Number of subjects: 60
Study 7795940 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of physical practice and rest periods (two sessions)
Number of subjects: 60
Study 7795940 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interpolated activity)
Number of subjects: 60
Study 1781537 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol preceded by 10 ml of 0.9% saline at 4 degrees C
Number of subjects: 0
Study 1781537 — intervention group
Group type: COMPARATOR
Intervention: Unmodified propofol
Number of subjects: 0
Study 1781537 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold propofol
Number of subjects: 0
Study 1781537 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with 0.05% lignocaine
Number of subjects: 0
Study 7457708 — intervention group
Group type: EXPERIMENTAL
Intervention: Escharotomy
Number of subjects: 18
Study 7457708 — intervention group
Group type: COMPARATOR
Intervention: No escharotomy (control group)
Number of subjects: 18
Study 30838890 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-h intravenous acetylcysteine regimen (200 mg/kg over 4 h, 50 mg/kg over 8 h)
Number of subjects: 38
Study 30838890 — intervention group
Group type: COMPARATOR
Intervention: 20-h intravenous acetylcysteine regimen (200 mg/kg over 4 h, 100 mg/kg over 16 h)
Number of subjects: 38
Study 30838890 — intervention group
Group type: EXPERIMENTAL
Intervention: NACSTOP‐abbreviated group
Number of subjects: 38
Study 30838890 — intervention group
Group type: COMPARATOR
Intervention: NACSTOP‐control group
Number of subjects: 38
Study 30838890 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute liver injury (ALI) group
Number of subjects: 38
Study 30838890 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatotoxicity group
Number of subjects: 38
Study 27718150 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 1000 IU vitamin D3
Number of subjects: 64
Study 27718150 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly 7000 IU vitamin D3
Number of subjects: 64
Study 27718150 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly 30,000 IU vitamin D3
Number of subjects: 64
Study 25401417 — intervention group
Group type: COMPARATOR
Intervention: Liberal erythrocyte transfusion strategy (transfusion when hemoglobin <9 g/dl)
Number of subjects: 198
Study 25401417 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive erythrocyte transfusion strategy (transfusion when hemoglobin <7 g/dl)
Number of subjects: 198
Study 25401417 — intervention group
Group type: COMPARATOR
Intervention: Liberal erythrocyte transfusion strategy
Number of subjects: 198
Study 23632054 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified vastus medialis saphenous nerve block
Number of subjects: 20
Study 23632054 — intervention group
Group type: EXPERIMENTAL
Intervention: Perifemoral saphenous nerve block
Number of subjects: 20
Study 23632054 — intervention group
Group type: COMPARATOR
Intervention: Below the knee field block
Number of subjects: 20
Study 23632054 — intervention group
Group type: EXPERIMENTAL
Intervention: Perifemoral vs Modified vastus medialis
Number of subjects: 20
Study 23632054 — intervention group
Group type: EXPERIMENTAL
Intervention: Perifemoral technique
Number of subjects: 20
Study 21070090 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic gadolinium (Gd) perfusion through the eustachian tube
Number of subjects: 20
Study 19249414 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimonthly tailored nurse-delivered behavioral telephone intervention
Number of subjects: 588
Study 19249414 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 588
Study 18042573 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assurance questionnaire
Number of subjects: 836
Study 18042573 — intervention group
Group type: COMPARATOR
Intervention: Standard process of obtaining informed consent
Number of subjects: 836
Study 15114056 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha therapy
Number of subjects: 27
Study 14649969 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (500 mg orally three times daily for three days)
Number of subjects: 138
Study 14649969 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B6 (10 mg orally three times daily for three days)
Number of subjects: 138
Study 10220013 — intervention group
Group type: EXPERIMENTAL
Intervention: G to A polymorphism at position -1438 of the 5-HT2A receptor gene
Number of subjects: 225
Study 10220013 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 225
Study 7604917 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun safety curriculum administered to preschoolers
Number of subjects: 12
Study 7604917 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12
Study 1369707 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine treatment
Number of subjects: 2184
Study 377896 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2-gel (0.25 mg)
Number of subjects: 22
Study 377896 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 22
Study 377896 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2-gel (0.25 mg) with nifedipine
Number of subjects: 22
Study 31790379 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal genetic variants as instruments for vitamin D
Number of subjects: 0
Study 31790379 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulations assessing proposed instruments jointly
Number of subjects: 0
Study 30472722 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative-pressure wound therapy (iNPWT)
Number of subjects: 0
Study 28052111 — intervention group
Group type: EXPERIMENTAL
Intervention: doxylamine/pyridoxine/dicylcomine
Number of subjects: 2308
Study 28052111 — intervention group
Group type: EXPERIMENTAL
Intervention: doxylamine/pyridoxine
Number of subjects: 2308
Study 28052111 — intervention group
Group type: EXPERIMENTAL
Intervention: dicylomine/pyridoxine
Number of subjects: 2308
Study 28052111 — intervention group
Group type: EXPERIMENTAL
Intervention: doxylamine
Number of subjects: 2308
Study 28052111 — intervention group
Group type: EXPERIMENTAL
Intervention: dicyclomine/pyridoxine
Number of subjects: 2308
Study 28052111 — intervention group
Group type: EXPERIMENTAL
Intervention: pyridoxine
Number of subjects: 2308
Study 28052111 — intervention group
Group type: EXPERIMENTAL
Intervention: dicyclomine
Number of subjects: 2308
Study 28052111 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2308
Study 26297314 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based facilitation intervention (NeoKIP)
Number of subjects: 0
Study 26297314 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators and participants' engagement
Number of subjects: 0
Study 23695519 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily SMS surveys for 60 days
Number of subjects: 96
Study 21266143 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness program
Number of subjects: 0
Study 21266143 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list group (Control)
Number of subjects: 0
Study 19884997 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Interscalene Block (CISB)
Number of subjects: 50
Study 19884997 — intervention group
Group type: COMPARATOR
Intervention: Single Interscalene Block combined with Continuous Intra-bursal Infusion of Ropivacaine (ISB-IB)
Number of subjects: 50
Study 17353401 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruboxistaurin (RBX) 32 mg/day
Number of subjects: 686
Study 17353401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 686
Study 15114199 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (3 x 2 puffs, 0.2 mg)
Number of subjects: 31
Study 15114199 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol combined with methylprednisolone (40 mg/day orally)
Number of subjects: 31
Study 15114199 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (2 puffs 10 min before anesthesia)
Number of subjects: 31
Study 15114199 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol combined with methylprednisolone
Number of subjects: 31
Study 11475710 — intervention group
Group type: EXPERIMENTAL
Intervention: Philips/Jordan 2‐Action Plaque Remover electric toothbrush
Number of subjects: 0
Study 11475710 — intervention group
Group type: COMPARATOR
Intervention: Oral‐B 35 Advantage manual toothbrush
Number of subjects: 0
Study 9737124 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (1.25 mg/d, n = 16)
Number of subjects: 28
Study 9737124 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 12)
Number of subjects: 28
Study 30652317 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - skin care programme with cream dispensers and electronic monitoring.
Number of subjects: 501
Study 30652317 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - standard care without the intervention.
Number of subjects: 501
Study 30652317 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - subgroup of HCWs with mild HD.
Number of subjects: 501
Study 28410857 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy (PST) - 6-8 sessions
Number of subjects: 0
Study 28410857 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 26088658 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Horseback Riding (THR)
Number of subjects: 127
Study 26088658 — intervention group
Group type: COMPARATOR
Intervention: Barn Activity (BA) Control
Number of subjects: 127
Study 23601071 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/day vitamin E and 150 mg/day vitamin C
Number of subjects: 12
Study 23601071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 19445435 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-fruit/vegetable dietary intervention
Number of subjects: 0
Study 19445435 — intervention group
Group type: COMPARATOR
Intervention: Delayed control ROs
Number of subjects: 0
Study 19263531 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified wheelchair with ESP mechanism
Number of subjects: 10
Study 19263531 — intervention group
Group type: COMPARATOR
Intervention: Standard dual handrim wheelchair
Number of subjects: 10
Study 14998946 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.25 mg daily
Number of subjects: 38
Study 14998946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 12207146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (hydrocortisone) 20 mg
Number of subjects: 100
Study 12207146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (hydrocortisone) 40 mg
Number of subjects: 100
Study 12207146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 9619929 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-augmented porous coating
Number of subjects: 116
Study 9619929 — intervention group
Group type: COMPARATOR
Intervention: Porous coating
Number of subjects: 116
Study 9619929 — intervention group
Group type: COMPARATOR
Intervention: Cemented fixation
Number of subjects: 116
Study 7639169 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 0
Study 7639169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Number of subjects: 0
Study 7639169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2515254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 20
Study 2515254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 619839 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen
Number of subjects: 82
Study 619839 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric oxygen
Number of subjects: 82
Study 619839 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric air
Number of subjects: 82
Study 619839 — intervention group
Group type: COMPARATOR
Intervention: Normobaric air
Number of subjects: 82